今日(2024年9月19日)微创医疗(00853)股价盘中大涨12.58%,收于5.35港元,成交金额近4000万港元,引发市场广泛关注。
公司旗下上海微创电生理医疗科技股份有限公司研发的EasyLoop 3D一次性使用磁定位环形标测导管在意大利、法国、瑞士、土耳其成功完成首批临床应用。据悉,海外专家对该产品在手术中的安全性和有效性给予了高度认可。
作为微创医疗的新一代产品,EasyLoop 3D导管是全球首款可360度全程磁定位的环形标测导管。与传统导管相比,它操控灵活性更强,减少了对患者的损伤,同时也提高了手术的精确度。该产品在欧洲市场的成功临床应用,标志着微创医疗的创新技术获得了国际认可,为公司开拓海外市场奠定了坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.